In patients with chronic hepatitis D, the decline of ≥2log HDV-RNA levels that remain detectable is associated with better clinical outcomes

被引：0
|
作者：
Palom, Adriana [1 ,2 ]
Rodriguez-Tajes, Sergio [2 ,3 ]
Bono, Ariadna [4 ]
Madejon, Antonio [2 ,5 ]
Riveiro Barciela, Mar [1 ,2 ]
机构：
[1] Hosp Univ Vall DHebron, Liver Unit, Barcelona, Spain
[2] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
[3] Hosp Clin Barcelona, IDIBAPS, Liver Unit, Barcelona, Spain
[4] Hosp Univ Politecn La Fe, Hepatol & Liver Transplantat Unit, Valencia, Spain
[5] Hosp Univ La Paz, Liver Unit, IdiPAZ, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
WED-168
引用
收藏
页码：S1099 / S1100
页数：2
相关论文
共 22 条
  • [1] One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease
    Palom, Adriana
    Sopena, Sara
    Riveiro-Barciela, Mar
    Carvalho-Gomes, Angela
    Madejon, Antonio
    Rodriguez-Tajes, Sergio
    Roade, Luisa
    Garcia-Eliz, Maria
    Garcia-Samaniego, Javier
    Lens, Sabela
    Berenguer-Hayme, Marina
    Rodriguez-Frias, Francisco
    Hernandez-Evole, Helena
    Isabel Gil-Garcia, Ana
    Barreira, Ana
    Esteban, Rafael
    Buti, Maria
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (04) : 462 - 469
  • [2] DIFFERENT LEVELS OF HDV-RNA AND HBV-DNA AND DIFFERENT EXPRESSION OF HBSAG ARE ASSOCIATED TO DIFFERENT OUTCOMES IN CHRONIC HDV INFECTION
    Romeo, R.
    Foglieni, B.
    Raffaele, L.
    Spreafico, M.
    Prati, D.
    Colombo, M.
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S155 - S156
  • [3] One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease (vol 54, pg 462, 2021)
    Palom, Adriana
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (11-12) : 1508 - 1508
  • [4] One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease (vol 54, pg 462, 2021)
    Palom, A.
    Sopena, S.
    Riveiro-Barciela, M.
    Carvalho-Gomes, A.
    Madejon, A.
    Rodriguez-Tajes, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (11) : 1473 - 1473
  • [5] Strong correlation between HBsAg, ALT and HDV-RNA levels in patients with chronic hepatitis D. Results of phase 3 D-LIVR study.
    Buti, Maria
    Etzion, Ohad
    Palom, Adriana
    Yardeni, David
    Nevo-Shor, Anat
    Munteanu, Daniela
    Choong, Ingrid
    Weissfeld, Lisa
    Barciela, Mar Riveiro
    Abu-Freha, Naim
    Barreira, Ana
    Howard, Rob
    Asselah, Tarik
    Lampertico, Pietro
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S269 - S269
  • [6] Monitoring interferon and lamivudine treatment by quantitative measurement of HBsAg and HDV-RNA serum levels in HBeAg-negative patients with chronic hepatitis delta
    Manesis, Emanuel K.
    Schina, Maria
    Gault, Elyanne
    Agelopoulou, Olga
    Papaioannou, Christos
    Kalligeros, Konstantine
    Arseniou, Vaios
    Manolakolpoulos, Spilios
    Hadziyannis, Emilia S.
    Le Gal, Frederic
    Koskinas, John
    Papatheodoridis, George
    Archimandritis, Athanasios J.
    [J]. HEPATOLOGY, 2006, 44 (04) : 673A - 673A
  • [7] MORE THAN A THIRD OF UNTREATED PATIENTS WITH CHRONIC HEPATITIS DELTA HAVE A DECREASE OR REACH UNDETECTABLE LEVELS OF HDV-RNA DURING NATURAL HISTORY
    Palom, Adriana
    Santisteve, Sara Sopena
    Carvalho-Gomes, Angela
    Madejon, Antonio
    Rodriguez-Tajesu, Sergio
    Roade Tato, Luisa
    Garcia Eliz, Maria
    Garcia-Samaniego, Javier
    Lens, Sabela
    Rodriguez-Frias, Francisco
    Berenguer, Marina
    Esteban-Mur, Rafael
    Riveiro Barciela, Mar
    Buti Ferret, Maria Asuncion
    [J]. HEPATOLOGY, 2020, 72 : 623A - 624A
  • [8] Baseline bile acid levels but not bile acid increases during bulevirtide treatment of hepatitis D are associated with HDV RNA decline
    Deterding, Katja
    Xu, Cheng-Jian
    Port, Kerstin
    Maasoumy, Benjamin
    Cornberg, Markus
    Wedemeyer, Heiner
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S857 - S857
  • [9] BASELINE ALT LEVELS BUT NOT HDV-RNA LEVELS ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT OF DELTA HEPATITIS: DATA FROM THE HIDIT-1 TRIAL
    Wedemeyer, Heiner
    Yurdaydin, Cihan
    Zachou, Kalliopi
    Erhardi, Annette
    Cakaloglu, Yilmaz
    Yalcin, Kendal
    Gurel, Selim
    Zeuzem, Stefan
    Bozkaya, Hakan
    Dalekos, George N.
    Manns, Michael P.
    [J]. HEPATOLOGY, 2008, 48 (04) : 713A - 714A
  • [10] HBV RNA levels are associated with virological response to treatment with pegylated interferon alpha in patients with chronic hepatitis D virus infection
    Sandmann, Lisa
    Bremer, Birgit
    Yurdaydin, Cihan
    Deterding, Katja
    Manns, Michael P.
    Cornberg, Markus
    Wedemeyer, Heiner
    Maasoumy, Benjamin
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S830 - S831
123